Cognitive impairment in MS: rehabilitation approaches

P Hämäläinen1, E Rosti-Otajärvi2

  • 1Masku Neurological Rehabilitation Centre, Masku, Finland.

Insights

Cognitive deficits, common in multiple sclerosis (MS), impact daily life. Neuropsychological rehabilitation shows promise for treating these MS-related cognitive impairments and improving quality of life.

Area of Science:

  • Neurology
  • Neuropsychology

Background:

  • Cognitive deficits affect 45%-70% of multiple sclerosis (MS) patients, manifesting variably.
  • Slowed information processing and memory/learning issues are most common MS cognitive deficits.
  • Both white and gray matter damage contribute to MS cognitive impairments, independent of physical disability or disease course.

Purpose of the Study:

  • To review the frequency and characteristics of cognitive impairments in MS.
  • To summarize findings on the effectiveness of neuropsychological rehabilitation for MS.
  • To highlight the impact of neurobehavioral deficits on daily living and quality of life.

Main Methods:

  • Literature review of studies on cognitive retraining and multimodal neuropsychological rehabilitation in MS.
  • Analysis of research on the prevalence and nature of cognitive deficits in multiple sclerosis.
  • Examination of the relationship between neurobehavioral deficits and quality of life in MS patients.

Main Results:

  • Cognitive impairments in MS are frequent and diverse, with slowed processing and memory issues being prominent.
  • Neuropsychological rehabilitation approaches, including cognitive retraining, demonstrate potential therapeutic benefits.
  • Neurobehavioral deficits significantly affect daily activities and overall quality of life for individuals with MS.

Conclusions:

  • Early diagnosis and treatment of cognitive impairments in MS are crucial.
  • Neuropsychological rehabilitation offers a promising avenue for managing cognitive deficits and improving outcomes in MS.
  • Addressing neurobehavioral deficits is essential for enhancing the quality of life in multiple sclerosis patients.